Changes for page Neurodiagnoses

Last modified by manuelmenendez on 2025/03/03 22:46
From version 34.1
edited by manuelmenendez
on 2025/02/01 13:54
Change comment: There is no comment for this version
To version 9.1
edited by manuelmenendez
on 2025/01/27 23:23
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -2,9 +2,9 @@
2 2  (((
3 3  (% class="container" %)
4 4  (((
5 -= //A new tridimensional diagnostic framework for CNS diseases// =
5 += //A new tridimensional diagnostic framework for CNS conditions// =
6 6  
7 -This project is focused on developing a novel nosological and diagnostic framework for CNS diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies.
7 +This project is focused on developing a novel nosological and diagnostic framework for neurological diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies.
8 8  We aim to create a structured, interpretable, and scalable diagnostic tool.
9 9  )))
10 10  )))
... ... @@ -15,23 +15,12 @@
15 15  (((
16 16  = What is this about and what can I find here? =
17 17  
18 -= **Overview** =
18 +== **Overview** ==
19 19  
20 +The //Tridimensional Diagnostic Framework// redefines how neurodegenerative diseases (NDDs) are classified by focusing on:
20 20  
21 -The classification and diagnosis of **central nervous system (CNS) diseases** have long been constrained by **traditional phenotype-based approaches**, which often fail to capture the **complex pathophysiological mechanisms, molecular biomarkers, and neuroanatomical changes** that drive disease progression. **Neurodegenerative and psychiatric disorders**, for example, exhibit significant **clinical overlap, co-pathology, and heterogeneity**, making current diagnostic models insufficient.
22 -
23 -This project proposes a **new diagnostic framework**—one that **shifts from symptom-based classifications** to an **etiology-driven, tridimensional system**. By integrating **genetics, proteomics, neuroimaging, computational modeling, and AI-powered annotations**, this approach aims to provide a **more precise, scalable, and biologically grounded method for diagnosing and managing CNS diseases**.
24 -
25 -The **AI-powered annotation system** plays a critical role by **structuring, interpreting, and tracking multi-modal data**, ensuring **real-time disease progression analysis, clinician decision support, and personalized treatment pathways**.
26 -
27 -=== **Project Aim** ===
28 -
29 -The project aims to develop a **tridimensional diagnostic framework** with an **AI-powered annotation system**, integrating **etiology, molecular biomarkers, and neuroanatomoclinical correlations** for **precise, standardized, and scalable CNS disease diagnostics**.
30 -
31 -The //Tridimensional Diagnostic Framework// redefines CNS diseases can be classified and diagnosed by focusing on:
32 -
33 -* **Axis 1**: Etiology (genetic or other causes of diseases).
34 -* **Axis 2**: Molecular Markers (biomarkers).
22 +* **Axis 1**: Etiology (genetic/sporadic and environmental factors).
23 +* **Axis 2**: Molecular Markers (biomarkers and proteinopathies).
35 35  * **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system).
36 36  
37 37  This methodology enables:
... ... @@ -40,28 +40,14 @@
40 40  * Integration of incomplete datasets using AI-driven probabilistic modeling.
41 41  * Stratification of patients for personalized treatment.
42 42  
43 -== **The Role of AI-Powered Annotation** ==
32 +== **Diagnostic Axes** ==
44 44  
45 -To enhance **standardization, interpretability, and clinical application**, the framework integrates **an AI-powered annotation system**, which:
46 -
47 -* **Assigns structured metadata tags** to diagnostic features.
48 -* **Provides real-time contextual explanations** for AI-based classifications.
49 -* **Tracks longitudinal disease progression** using timestamped AI annotations.
50 -* **Improves AI model transparency** through interpretability tools (e.g., SHAP analysis).
51 -* **Facilitates decision-making for clinicians** by linking annotations to standardized biomedical ontologies (SNOMED, HPO).
52 -
53 -== **The case of neurodegenerative diseases** ==
54 -
55 -There have been described these 3 diagnostic axes:
56 -
57 -[[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
58 -
59 59  * (((
60 60  **Axis 1: Etiology**
61 61  
62 62  * //Description//: Focuses on genetic and sporadic causes, identifying risk factors and potential triggers.
63 63  * //Examples//: APOE ε4 as a genetic risk factor, or cardiovascular health affecting NDD progression.
64 -* //Tests//: Genetic testing, lifestyle, and cardiovascular screening.
39 +* //Tests//: Genetic testing, lifestyle and cardiovascular screening.
65 65  )))
66 66  * (((
67 67  **Axis 2: Molecular Markers**
... ... @@ -85,28 +85,24 @@
85 85  * **Research**: By stratifying patients, reduces cohort heterogeneity in clinical trials.
86 86  * **Clinical Practice**: Provides dynamic diagnostic annotations with timestamps for longitudinal tracking.
87 87  
88 -== How to Contribute ==
63 +== Who has access? ==
89 89  
65 +We welcome contributions from the global community. Let’s build the future of neurological diagnostics together!
66 +
67 +== How to Contribute: ==
68 +
90 90  * Access the `/docs` folder for guidelines.
91 91  * Use `/code` for the latest AI pipelines.
92 92  * Share feedback and ideas in the wiki discussion pages.
93 93  
94 -== Key Objectives ==
73 +== Key Objectives: ==
95 95  
96 96  * Develop interpretable AI models for diagnosis and progression tracking.
97 97  * Integrate data from Human Phenotype Ontology (HPO), Gene Ontology (GO), and other biomedical resources.
98 98  * Foster collaboration among neuroscientists, AI researchers, and clinicians.
99 -
100 -== Who has access? ==
101 -
102 -We welcome contributions from the global community. Let’s build the future of neurological diagnostics together!
103 103  )))
104 104  
105 105  
106 -
107 -
108 -
109 -
110 110  (% class="col-xs-12 col-sm-4" %)
111 111  (((
112 112  {{box title="**Contents**"}}
... ... @@ -113,14 +113,11 @@
113 113  {{toc/}}
114 114  {{/box}}
115 115  
116 -== Main contents ==
87 +== Main contents: ==
117 117  
118 118  * `/docs`: Documentation and contribution guidelines.
119 119  * `/code`: Machine learning pipelines and scripts.
120 120  * `/data`: Sample datasets for testing.
121 121  * `/outputs`: Generated models, visualizations, and reports.
122 -* [[Methodology>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Methodology/]]
123 -* [[Results>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Results/]]
124 -* [[to-do-list>>to-do-list]]
125 125  )))
126 126  )))
tridimensional.png
Author
... ... @@ -1,1 +1,0 @@
1 -XWiki.manuelmenendez
Size
... ... @@ -1,1 +1,0 @@
1 -149.8 KB
Content
Collaboratory.Apps.Collab.Code.CollabClass[0]
Public
... ... @@ -1,1 +1,1 @@
1 -Yes
1 +No
XWiki.XWikiRights[3]
Allow/Deny
... ... @@ -1,1 +1,0 @@
1 -Allow
Levels
... ... @@ -1,1 +1,0 @@
1 -view
Users
... ... @@ -1,1 +1,0 @@
1 -XWiki.XWikiGuest
XWiki.XWikiRights[4]
Allow/Deny
... ... @@ -1,1 +1,0 @@
1 -Allow
Groups
... ... @@ -1,1 +1,0 @@
1 -XWiki.XWikiAllGroup
Levels
... ... @@ -1,1 +1,0 @@
1 -view